Boothbay Fund Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-66,782
Closed -$6.78M 2185
2025
Q4
$6.78M Buy
+66,782
New +$5.36M 0.1% 214
2024
Q2
Sell
-329,929
Closed -$22.8M 1630
2024
Q1
$22.8M Buy
+329,929
New +$20.9M 0.44% 28
2021
Q1
Sell
-1,870
Closed -$256K 1621
2020
Q4
$248K Buy
+1,870
New +$226K 0.01% 1021

Other funds holding EXAS

Boothbay Fund Management's EXAS Position: Q1 2026 in Review

Boothbay Fund Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 66,782 shares — an estimated $6.78M sold.

Boothbay Fund Management first reported a position in EXAS in Q4 2020 and held it in 3 quarters. The position peaked at $22.8M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Boothbay Fund Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 66,782 Exact Sciences shares in Q1 2026, an estimated $6.78M.
  • Boothbay Fund Management first reported a position in Exact Sciences in Q4 2020 and held it in 3 quarters.
  • Boothbay Fund Management's Exact Sciences position peaked at $22.8M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.